In a significant step forward for global healthcare collaboration, the Research Center for Chinese Medicine Innovation (RCMI) and the Shanghai University of Traditional Chinese Medicine Affiliated Yueyang Hospital of Integrated Traditional Chinese and Western Medicine (hereinafter "Yueyang Hospital") officially signed a Memorandum of Understanding (MoU) on August 4, 2026.
The ceremony was held at the state-of-the-art facilities of the PolyU Shenzhen Research Institute (SZRI), bringing together delegations from both prestigious institutions to formalize a partnership dedicated to advancing the frontiers of Traditional Chinese Medicine (TCM) and Western medical integration.
Key Collaboration Scope:
- Joint R&D: Focused on kidney diseases, dermatological external drugs, tumor immunology, gynecology, organ anti-aging, and medicine-food homology.
- Talent & Education: Joint student training, faculty exchanges, and regular academic symposiums.
- Resource Integration: Shared access to clinical databases, literature, and research facilities.
Prof. Lee signed the MoU on behalf of RCMI.This alliance underscores SZRI's commitment to serving as a hub for international medical innovation. As both institutions move forward, the partnership aims to develop new treatment protocols for complex chronic diseases and share findings with the global medical community.
With this MoU in place, RCMI and Yueyang Hospital are poised to lead the next wave of breakthroughs in integrative medicine, ensuring that the wisdom of tradition meets the precision of modern science.
